Lisata Therapeutics Statistics
Total Valuation
LSTA has a market cap or net worth of $28.63 million. The enterprise value is $14.76 million.
Important Dates
The last earnings date was Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LSTA has 9.03 million shares outstanding. The number of shares has increased by 4.54% in one year.
| Current Share Class | 9.03M |
| Shares Outstanding | 9.03M |
| Shares Change (YoY) | +4.54% |
| Shares Change (QoQ) | +2.33% |
| Owned by Insiders (%) | 21.06% |
| Owned by Institutions (%) | 7.84% |
| Float | 7.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 163.64 |
| Forward PS | n/a |
| PB Ratio | 2.57 |
| P/TBV Ratio | 2.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 86.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.23
| Current Ratio | 4.23 |
| Quick Ratio | 3.94 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -91.41% and return on invested capital (ROIC) is -60.31%.
| Return on Equity (ROE) | -91.41% |
| Return on Assets (ROA) | -50.26% |
| Return on Invested Capital (ROIC) | -60.31% |
| Return on Capital Employed (ROCE) | -161.06% |
| Weighted Average Cost of Capital (WACC) | 8.70% |
| Revenue Per Employee | $8,095 |
| Profits Per Employee | -$778,619 |
| Employee Count | 21 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -387,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +45.41% in the last 52 weeks. The beta is 0.81, so LSTA's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +45.41% |
| 50-Day Moving Average | 4.18 |
| 200-Day Moving Average | 3.09 |
| Relative Strength Index (RSI) | 37.24 |
| Average Volume (20 Days) | 53,420 |
Short Selling Information
The latest short interest is 70,246, so 0.78% of the outstanding shares have been sold short.
| Short Interest | 70,246 |
| Short Previous Month | 51,644 |
| Short % of Shares Out | 0.78% |
| Short % of Float | 0.99% |
| Short Ratio (days to cover) | 0.76 |
Income Statement
In the last 12 months, LSTA had revenue of $170,000 and -$16.35 million in losses. Loss per share was -$1.86.
| Revenue | 170,000 |
| Gross Profit | 170,000 |
| Operating Income | -17.30M |
| Pretax Income | -16.74M |
| Net Income | -16.35M |
| EBITDA | -17.20M |
| EBIT | -17.30M |
| Loss Per Share | -$1.86 |
Full Income StatementBalance Sheet
The company has $13.06 million in cash and n/a in debt, with a net cash position of $13.06 million or $1.45 per share.
| Cash & Cash Equivalents | 13.06M |
| Total Debt | n/a |
| Net Cash | 13.06M |
| Net Cash Per Share | $1.45 |
| Equity (Book Value) | 10.67M |
| Book Value Per Share | 1.20 |
| Working Capital | 10.71M |
Full Balance SheetCash Flow
| Operating Cash Flow | -13.63M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 105,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -13.63M |
| FCF Per Share | -$1.51 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -10,178.82% |
| Pretax Margin | -9,845.88% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
